Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

Research output: Contribution to journal › Article › peer-review

Standard Standard

Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. / Hughes, D.; Hughes, D.A.; Dubois, D.
In: Pharmacoeconomics, Vol. 22, No. 16, 01.01.2004, p. 1047-1059.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Hughes, D, Hughes, DA & Dubois, D 2004, 'Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.', Pharmacoeconomics, vol. 22, no. 16, pp. 1047-1059.

APA

Hughes, D., Hughes, D. A., & Dubois, D. (2004). Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. Pharmacoeconomics, 22(16), 1047-1059.

CBE

Hughes D, Hughes DA, Dubois D. 2004. Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. Pharmacoeconomics. 22(16):1047-1059.

MLA

Hughes, D., D.A. Hughes and D. Dubois. "Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.". Pharmacoeconomics. 2004, 22(16). 1047-1059.

VancouverVancouver

Hughes D, Hughes DA, Dubois D. Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. Pharmacoeconomics. 2004 Jan 1;22(16):1047-1059.

Author

Hughes, D. ; Hughes, D.A. ; Dubois, D. / Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. In: Pharmacoeconomics. 2004 ; Vol. 22, No. 16. pp. 1047-1059.

RIS

TY - JOUR

T1 - Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

AU - Hughes, D.

AU - Hughes, D.A.

AU - Dubois, D.

PY - 2004/1/1

Y1 - 2004/1/1

KW - PHARMACOLOGY & PHARMACY

M3 - Article

VL - 22

SP - 1047

EP - 1059

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 16

ER -